全文获取类型
收费全文 | 2683篇 |
免费 | 158篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 76篇 |
妇产科学 | 103篇 |
基础医学 | 321篇 |
口腔科学 | 52篇 |
临床医学 | 298篇 |
内科学 | 584篇 |
皮肤病学 | 36篇 |
神经病学 | 253篇 |
特种医学 | 89篇 |
外科学 | 309篇 |
综合类 | 11篇 |
一般理论 | 1篇 |
预防医学 | 205篇 |
眼科学 | 61篇 |
药学 | 193篇 |
中国医学 | 11篇 |
肿瘤学 | 229篇 |
出版年
2023年 | 58篇 |
2022年 | 19篇 |
2021年 | 127篇 |
2020年 | 81篇 |
2019年 | 110篇 |
2018年 | 110篇 |
2017年 | 77篇 |
2016年 | 92篇 |
2015年 | 95篇 |
2014年 | 149篇 |
2013年 | 146篇 |
2012年 | 207篇 |
2011年 | 244篇 |
2010年 | 144篇 |
2009年 | 113篇 |
2008年 | 178篇 |
2007年 | 170篇 |
2006年 | 168篇 |
2005年 | 118篇 |
2004年 | 92篇 |
2003年 | 99篇 |
2002年 | 76篇 |
2001年 | 21篇 |
2000年 | 12篇 |
1999年 | 17篇 |
1998年 | 14篇 |
1997年 | 10篇 |
1996年 | 4篇 |
1995年 | 8篇 |
1994年 | 4篇 |
1993年 | 2篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 9篇 |
1989年 | 7篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 5篇 |
1984年 | 4篇 |
1982年 | 2篇 |
1978年 | 3篇 |
1973年 | 2篇 |
1972年 | 3篇 |
1971年 | 4篇 |
1970年 | 4篇 |
1969年 | 2篇 |
1968年 | 5篇 |
1967年 | 1篇 |
1964年 | 1篇 |
1932年 | 1篇 |
排序方式: 共有2847条查询结果,搜索用时 15 毫秒
1.
2.
Arutiunian Vardan Lopukhina Anastasiya Minnigulova Alina Shlyakhova Anastasia Davydova Elizaveta Pereverzeva Darya Sorokin Alexander Tyushkevich Svetlana Mamokhina Uliana Danilina Kamilla Dragoy Olga 《Journal of autism and developmental disorders》2022,52(2):584-599
Journal of Autism and Developmental Disorders - The purpose of the present research was to comprehensively assess the language abilities of Russian primary-school-aged children with Autism Spectrum... 相似文献
3.
Anastasia Therianou Magdalini Vasiadi Danae A. Delivanis Theodora Petrakopoulou Alexandra Katsarou‐Katsari Christina Antoniou Alexandros Stratigos Irene Tsilioni Andreas Katsambas Dimitris Rigopoulos Theoharis C. Theoharides 《Experimental dermatology》2019,28(1):72-75
Psoriasis is characterized by keratinocyte proliferation and chronic inflammation, but the pathogenesis is still unclear. Dysregulated mitochondria (mt) could lead to reduced apoptosis and extracellular secretion of mtDNA, acting as “innate pathogen” triggering inflammation. Serum was obtained from healthy volunteers and psoriatic patients. Mitochondrial DNA was extracted from the serum and amplified with quantitative PCR (qPCR). Punch biopsies were obtained from lesional and non‐lesional psoriatic skin (10 cm apart) and from healthy volunteers, were placed in RNA later and were stored at ?80°C until RNA was extracted and cDNA was synthesized; gene expression of uncoupling protein 2 (UCP2), Dynamin‐related protein 1 (Drp1) and calcineurin, involved in the regulation of mitochondria function, was detected with qPCR. Mitochondrial DNA was significantly increased (7s, P = 0.0496 and Cytochrome B, CytB, P = 0.0403) in the serum of psoriatic patients (n = 63) as compared to controls (n = 27). Gene expression was significantly reduced for UCP2 (P = 0.0218), Drp1 (P = 0.0001) and calcineurin (P = 0.0001) in lesional psoriatic skin, as compared to non‐lesional or control skin. Increased serum extracellular mtDNA in psoriatic patients and decreased expression of mitochondrial regulatory proteins in psoriatic skin suggest increased inflammation and reduced keratinocyte apoptosis, respectively. Inhibitors of mtDNA secretion and/or UCP2 stimulants may be potential treatment options. 相似文献
4.
5.
6.
7.
8.
9.
Anastasia L. Armbruster Kristen Bova Campbell Milan G. Kahanda Phillip S. Cuculich 《Pharmacotherapy》2022,42(3):250-262
The pathogenesis of arrhythmias is complex and multifactorial. The role of inflammation in the pathogenesis of both atrial and ventricular arrhythmias (VA) has been explored. However, developing successful pharmacotherapy regimens based on those pathways has proven more of a challenge. This narrative review provides an overview of five common arrhythmias impacted by inflammation, including atrial fibrillation (AF), myocardial infarction, arrhythmogenic cardiomyopathy, cardiac sarcoidosis, and QT prolongation, and the potential role for anti-inflammatory therapy in their management. We identified arrhythmias and arrhythmogenic disease states with the most evidence linking pathogenesis to inflammation and conducted comprehensive searches of United States National Library of Medicine MEDLINE® and PubMed databases. Although a variety of agents have been studied for the management of AF, primarily in an effort to reduce postoperative AF following cardiac surgery, no standard anti-inflammatory agents are used in clinical practice at this time. Although inflammation following myocardial infarction may contribute to the development of VA, there is no clear benefit with the use of anti-inflammatory agents at this time. Similarly, although inflammation is clearly linked to the development of arrhythmias in arrhythmogenic cardiomyopathy, data demonstrating a benefit with anti-inflammatory agents are limited. Cardiac sarcoidosis, an infiltrative disease eliciting an immune response, is primarily treated by immunosuppressive therapy and steroids, despite a lack of primary literature to support such regimens. In this case, anti-inflammatory agents are frequently used in clinical practice. The pathophysiology of arrhythmias is complex, and inflammation likely plays a role in both onset and duration, however, for most arrhythmias the role of pharmacotherapy targeting inflammation remains unclear. 相似文献
10.